International Clinical Trial: An Exploratory Phase II, Single-Center, Single-Arm Study of Becotatug Vedotin in Patients with Platinum-Resistant Advanced Cervical Cancer in the Later-Line Setting

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122667) titled 'An Exploratory Phase II, Single-Center, Single-Arm Study of Becotatug Vedotin in Patients with Platinum-Resistant Advanced Cervical Cancer in the Later-Line Setting' on April 16.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Obstetris & Gynecology Hospital of Fudan University

Condition: Advanced cervical cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-16

Target Sample Size: Becotatug Vedotin treatment group:28;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=318405

Published by HT ...